Navigation Links
Golden Meditech Increases Stakes in Cordlife, Largest Cord Blood Bank Operator in Southeast Asia
Date:10/28/2008

HONG KONG, Oct. 28 /Xinhua-PRNewswire-FirstCall/ -- Golden Meditech Company Limited ("Golden Meditech" or "the Group", HKEx: 8180) is pleased to announce today that the Group has increased shareholding in Cordlife, Southeast Asia's largest umbilical cord blood bank operator listed on Australia Stock Exchange, to 18.9%, and became the latter's single largest shareholder at a consideration of 2.4 million Australian Dollars (equivalent to HK$12 million).

Mr. KAM Yuen, Chairman of Golden Meditech, explained that Cordlife not only owns the exclusive license of operating cord blood bank services in Indonesia and the only one operating license issued to a foreign entity in India, but also has operations in Hong Kong, Macau, Australia, Singapore, Thailand, the Philippines, etc.

Mr. KAM said that raising the strategic ownership of shareholding in Cordlife has not only extended the arms of Group's cord blood bank business beyond China, to the rest of the world's most-populated countries in Asia- Pacific regions, but also helps improve the success rate of HLA (human leukocyte antigen) marching in Asia as well, which can benefit a large number of patients in need of stem cell transplants.

He emphasized that along with the further development in India, Indonesia and other Asian states, where the cord blood bank services just began to gain the spotlights, Asia will soon become the world's largest market of cord blood bank services.

According to the statistics of the United Nations Population Division, almost 61% of the world's population, approximately 3.87 billion people reside in Asia. Besides, Asia has about 80 million newborn babies a year, who are the target customers of the cord blood bank services.

He said that despite the ongoing financial crisis that has induced extreme volatility of the capital market, healthcare industry on its own is less affected by such business cycles. The management will cautiously look into investment opportunities that will strengthen all key operations.

This transaction was completed at a time when the stock prices and the exchange rates of Australian dollar were in our favor. It is considered conducive to not only the further development of the Group's cord blood bank operations, but also the enhancement of shareholders' value and returns.

For inquiry, please kindly contact:

Investor Relations Division

Golden Meditech Company Limited

Tel: +852-3605-8138

Fax: +852-3605-8181

Email: ir@goldenmeditech.com


'/>"/>
SOURCE Golden Meditech Company Limited
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Golden Corrals Good Health Recipe for the Flu Season
2. National Energy Services Receives Repeat Orders From Golden Living and Cathedral Rock Skilled Nursing Facilities
3. Giving Back to the Community Golden Corral Style
4. Golden Doctor of Chiropractic Elected President of the Colorado Chiropractic Association
5. Kaiser Permanente and Golden State Warriors Team Up to Fight Childhood Obesity
6. Histochemistry is the golden standard in the diagnosis of carcinosarcomas
7. Emmy(R)- and Golden Globe(R)-Nominated Actress Marcia Cross and Lifetime Television Deliver 20 Million Online Petition Signatures to Capitol Hill to Urge Congress to Stop Drive-Through Mastectomies
8. Author Elizabeth Golden and Dancer Sarah Patellos to Serve as National Spokespersons for the National Scoliosis Foundation
9. American Airlines Honors Flight Attendants at Golden Heart Awards Ceremony
10. Golden State Medical Supply Selects IBM Technology to Comply With California Prescription Drug Pedigree Regulations
11. Golden Rainbow Takes a Musical Journey for Its 22nd Annual Ribbon of Life Production Show
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... Fairfax, VA (PRWEB) , ... May 26, 2017 ... ... is pleased to announce a new educational seminar to focus on current legislative ... Regulatory News(LEARN) seminar will begin at 1 p.m. Sunday, Sept. 10, and will ...
(Date:5/26/2017)... ... May 26, 2017 , ... ... copper, antimicrobial, mesh back 24/7 task chair specifically designed for clinical areas. Genie ... are thrilled to partner with Cupron® to provide customers with a game changing ...
(Date:5/26/2017)... , ... May 26, 2017 , ... Rob Lowe acts ... upcoming production of the series is on hiking in American. Viewers can reconnect with ... the great benefits of hiking. , Many consumers have looked for an inventive new ...
(Date:5/26/2017)... ... ... “Just What Happened in the Garden of Eden”: retells the stories of three Bible figures ... of published author, Penelope Colt, mother, trader, horse farmer, artist and a former GM journeyman. ... three. At six, they moved to Dayton, Ohio, where Penny graduated high school. ...
(Date:5/24/2017)... ... May 24, 2017 , ... Dr. Alan I. Benvenisty, MD is dual board ... He is known for his distinguished expertise and experience in the diagnosis and treatment ... training in treating renovascular disease and aortic aneurysm . He is known for ...
Breaking Medicine News(10 mins):
(Date:5/9/2017)... 9, 2017  Semler Scientific, Inc. (OTCQB: SMLR), ... to improve the clinical effectiveness and efficiency of ... first quarter ended March 31, 2017. ... customers to identify when preventive care options are ... like heart attacks or strokes occur," said ...
(Date:5/6/2017)... Provista , a proven leader in the supply chain industry ... Jim Cunniff as the company,s new president and CEO. ... Provista, including most recently serving as the president and CEO ... He assumed his new role with Provista on May 1, ... says Jody Hatcher , president, Sourcing and Collaboration Services ...
(Date:5/4/2017)... 4, 2017  Fortuna Fix Inc. (" Fortuna "), ... first to eliminate the need for embryonic and fetal stem ... neurodegenerative diseases. Fortuna announced today the ... Michael Fehlings , MD, PhD; Father Kevin FitzGerald , ... and Professor James Giordano , PhD. "We ...
Breaking Medicine Technology: